Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia

We evaluated long-term outcomes of 60 patients with chronic lymphocytic leukemia treated with an initial therapy of lenalidomide. At a median follow-up of 4 years, time-to-treatment failure has not been reached and overall survival is 82%. Thirty-five (58%) patients had a response lasting >36 mon...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Strati, Paolo, Keating, Michael J., Wierda, William G., Badoux, Xavier C., Calin, Steliana, Reuben, James M., O’Brien, Susan, Kornblau, Steven M., Kantarjian, Hagop M., Gao, Hui, Ferrajoli, Alessandra
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2013
Θέματα:
Lymphoid Neoplasia
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4123325/
https://ncbi.nlm.nih.gov/pubmed/23801633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-04-495341
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια